Aug 2026· Physiology and Behavior· pp.
115470
· 0 citations· 46 references
Medicine
TL;DR
It is indicated that prior exposure to N-ADA can influence reward- and anxiety-related behaviors specifically under conditions of CB1 blockade/GPR55 modulation and an interaction with endocannabinoid signaling (or other rimonabant-sensitive mechanisms) is indicated.
Abstract
The endovanilloid N-arachidonoyl dopamine (N-ADA) is a lipid mediator associated with nociception and inflammation, but its effects on reward and anxiety remain unclear. We examined the behavioral impact of subacute N-ADA pre-exposure on conditioned place preference (CPP) and anxiety-like behavior in the circular open-field test (COF), assessed both under basal conditions and after acute CB1 blockade/GPR55 modulation with rimonabant. Male BALB/c mice were pre-exposed for four days to either vehicle (10% ethanol) or N-ADA (0.1 mg/kg). A counterbalanced CPP protocol was then conducted over eight days. Place preference was assessed before and after rimonabant administration (0.1 mg/kg), and anxiety-like behavior was evaluated using the COF following rimonabant. N-ADA exposure alone did not significantly modify place preference compared to baseline (p > 0.05). However, following rimonabant administration, N-ADA-exposed mice displayed a significant increase in preference for the drug-paired compartment (p < 0.05) and increased anxiety-like behavior in the COF (p < 0.05). These findings indicate that prior exposure to N-ADA can influence reward- and anxiety-related behaviors specifically under conditions of CB1 blockade/GPR55 modulation. The results support the modulatory role of N-ADA on reward- and anxiety-related behaviors at the dose tested, indicating an interaction with endocannabinoid signaling (or other rimonabant-sensitive mechanisms).
Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as promising pharmacotherapeutics for alcohol use disorder (AUD). Here, we examined the effects of semaglutide, a long-acting GLP-1 receptor agonist, on alcohol intake and anxiety-related behaviors in Marchigian Sardinian alcohol-preferring rats, a model ch...
M. Palmisano, Hela Mrizak, Angela E. Gonzalez et al.· Neuropharmacology· 0 citations
Dysregulation of the noradrenergic system has been implicated in the pathophysiology of schizophrenia. Although α2-adenergic receptor (α2-AR) agonists may alleviate positive symptoms, their effects on cognitive and negative symptoms remain controversial. This study aimed to characterize the dose-dependent effects of re...
G. Horvath, S. Plesz, E. Ducza et al.· Neuropharmacology· 0 citations
Opioid addiction is characterized by persistent drug seeking; the main objective of addiction treatment is to prevent relapses, which remains the primary limitation of pharmacological therapy. In the present work, the role of bhilawanol (BWL) on morphine conditioned place preference (CPP) and the anxiety-like behavior...
Aleena Muskan· Natural Resources for Human...· 0 citations
The development of hyperalgesia (i.e., enhanced physical pain and/or psychological distress) during chronic fentanyl use plays a vital role in the continued and accelerated use of this potent synthetic opioid. Numerous biochemical changes in the brain, such as changes in redox status, are thought to contribute to the d...
Paulina M. Getsy, Santhosh M. Baby, Gregory A. Coffee et al.· Pharmacology, Biochemistry a...· 0 citations
Background: Diazepam is a benzodiazepine that enhances inhibitory neurotransmission mediated by γ-aminobutyric acid type A (GABA(_A)) receptors. It has several effects on the central nervous system, including alterations in nociception, motor coordination, and cognitive function. Omega-3 fatty acids, important componen...
M. Chowdhury, Rebecca Cynthia Gomes, Kona Basak· Journal of Pharmaceutical Re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.